MoneyBall Medicine

Andrew A. Radin: From Validation to Pharma Pipeline—How AI is Finding the Patterns in Data (AI Biopharma Special Series Part 1)

Episode Summary

Harry interviews Andrew A. Radin, co-founder and CEO of twoXAR, an AI-driven drug discovery startup that unifies disparate data to identify potential disease treatments. This episode is Part 1 of a 6-part special series recorded at the AI Applications Summit produced in Boston by Corey Lane partners in October 2018.

Episode Notes

Harry interviews Andrew A. Radin, co-founder and CEO of twoXAR, a Mountain View, CA-based AI-driven drug discovery startup that unifies disparate data to identify potential disease treatments. This episode is Part 1 of a 6-part special series recorded at the AI Applications Summit produced in Boston by Corey Lane partners in October 2018.

How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch: